Will the Russian war in Ukraine unleash larger epidemics of HIV, TB and associated conditions and diseases in Ukraine?


Journal

Harm reduction journal
ISSN: 1477-7517
Titre abrégé: Harm Reduct J
Pays: England
ID NLM: 101153624

Informations de publication

Date de publication:
01 09 2023
Historique:
received: 07 06 2023
accepted: 22 08 2023
medline: 7 9 2023
pubmed: 2 9 2023
entrez: 1 9 2023
Statut: epublish

Résumé

The Russian war in Ukraine poses many risks for the spread of HIV, TB and associated conditions, including possible increases in the numbers of people who inject drugs or engage in sex work in the years ahead. Ukrainian civil society and volunteer efforts have been able to maintain and at times expand services for HIV Key Populations. The extent of mutual-aid and volunteer efforts as well as the continued strength and vitality of harm reduction organizations such as the Alliance for Public Health and the rest of civil society will be crucial resources for postwar efforts to assist Key Populations and prevent the spread of HIV, TB and other diseases. The postwar period will pose great economic and political difficulties for Ukrainians, including large populations of people physically and/or psychically damaged and in pain who might become people who inject drugs. Local and international support for public health and for harm reduction will be needed to prevent potentially large-scale increases in infectious disease and related mortality.

Identifiants

pubmed: 37658448
doi: 10.1186/s12954-023-00855-1
pii: 10.1186/s12954-023-00855-1
pmc: PMC10472698
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

119

Subventions

Organisme : NIDA NIH HHS
ID : P30 DA011041
Pays : United States

Informations de copyright

© 2023. BioMed Central Ltd., part of Springer Nature.

Références

AIDS Behav. 2013 Jul;17(6):1915-25
pubmed: 23564029
Int J Drug Policy. 2016 Jun;32:11-6
pubmed: 27198555
J Int AIDS Soc. 2020 Aug;23(8):e25608
pubmed: 32851812
Int J Drug Policy. 2021 Jun;92:103127
pubmed: 33549464
Subst Use Misuse. 2006;41(10-12):1637-51
pubmed: 17002996
AIDS Behav. 2016 Aug;20(8):1808-20
pubmed: 26796384
Confl Health. 2014 Aug 20;8:13
pubmed: 25177360
Am J Public Health. 2011 Feb;101(2):344-9
pubmed: 21164088
Eur Respir J. 2022 Apr 21;59(4):
pubmed: 35450921
Lancet Infect Dis. 2011 May;11(5):363-71
pubmed: 21354861
Int J Environ Res Public Health. 2022 Jan 17;19(2):
pubmed: 35055817
Med Confl Surviv. 2021 Dec;37(4):293-318
pubmed: 34544291
AIDS. 2016 Nov 28;30(18):2885-2890
pubmed: 27824626
Nat Genet. 2015 Mar;47(3):242-9
pubmed: 25599400
AIDS Behav. 2020 Jan;24(1):257-273
pubmed: 31313092
Int J Infect Dis. 2022 Sep;122:46-62
pubmed: 35577247
Emerg Infect Dis. 2020 Mar;26(3):481-490
pubmed: 32091369
Glob Public Health. 2021 Aug-Sep;16(8-9):1167-1186
pubmed: 33843462
Curr Psychiatry Rep. 2019 Jun 3;21(7):47
pubmed: 31161306
J Infect Dis. 2008 Mar 15;197(6):867-70
pubmed: 18269317
Lancet Infect Dis. 2022 May;22(5):e129
pubmed: 35334206
AIDS Behav. 2017 Sep;21(9):2561-2578
pubmed: 27752870
Science. 2022 Aug 5;377(6606):583
pubmed: 35926018
J Clin Microbiol. 2014 Aug;52(8):2868-75
pubmed: 24871219
AIDS. 2001 Apr;15 Suppl 3:S4-12
pubmed: 11421181
Int J Drug Policy. 2009 May;20(3):283-91
pubmed: 19101131
Can Commun Dis Rep. 2017 Mar 02;43(3-4):62-66
pubmed: 29770066
Subst Use Misuse. 2015;50(7):878-84
pubmed: 25775259
J Addict Dis. 2015;34(2-3):248-54
pubmed: 26076380
AIDS. 2002 Nov 22;16(17):2245-52
pubmed: 12441795
J Addict Dis. 2015;34(1):55-62
pubmed: 25774744
N Engl J Med. 2003 Feb 13;348(7):666-7
pubmed: 12584383
Clin Infect Dis. 2017 Sep 01;65(5):796-802
pubmed: 28482025
Health Place. 2012 Mar;18(2):218-28
pubmed: 22047790
Eur J Public Health. 2022 Aug 1;32(4):517-518
pubmed: 35913795
Glob Public Health. 2022 Jun 27;:1-13
pubmed: 35760779
J Community Psychol. 2022 Jan;50(1):385-408
pubmed: 34115390
Eur Respir Rev. 2018 Jun 13;27(148):
pubmed: 29898905
Eur J Public Health. 2019 Dec 1;29(6):1141-1146
pubmed: 31230084
AIDS. 2015 Jun 19;29(10):1239-46
pubmed: 26035323
BMC Public Health. 2022 Jan 28;22(1):189
pubmed: 35086497
Subst Use Misuse. 2015;50(7):899-902
pubmed: 26158751
Lancet HIV. 2022 Jun;9(6):e438-e448
pubmed: 35576942
Am J Orthopsychiatry. 2021;91(4):499-513
pubmed: 33900102
PNAS Nexus. 2023 Jan 20;2(3):pgad008
pubmed: 36896134
Lancet HIV. 2022 Apr;9(4):e230
pubmed: 35286859

Auteurs

Samuel R Friedman (SR)

NYU Langone Health, New York, NY, USA.

Pavlo Smyrnov (P)

Alliance for Public Health, Kyiv, Ukraine.

Tetyana I Vasylyeva (TI)

Division of Infectious Diseases and Global Public Health, UC San Diego, San Diego, CA, USA. tvasylyeva@health.ucsd.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH